Showing 2451-2460 of 6036 results for "".
- Ophthalmic World Leaders (OWL) Names First MD President and Other Leadership Changes for 2026https://modernod.com/news/ophthalmic-world-leaders-owl-names-first-md-president-and-other-leadership-changes-for-2026/2484293/Ophthalmic World Leaders (OWL) announces the appointment of Renee Bovelle, MD, as its new President. OWL also welcomes three new members to its Board of Directors: Kevin M. Douglas, MD (Medical Director, Eye Care – Retina, AbbVie), Maáza Martin (S
- Locus Biosciences Announces Collaboration with Viatris to Develop Antibacterial Therapies for Ophthalmic Infectionshttps://modernod.com/news/locus-biosciences-announces-collaboration-with-viatris-to-develop-antibacterial-therapies-for-ophthalmic-infections/2484292/Locus Biosciences announced a research collaboration agreement with Viatris to develop novel engineered bacteriophage therapies targeting ophthalmic bacterial infections. While financial terms of the deal were not disc
- NEJM Publishes Study Demonstrating Vision Restoration with Brain-Computer Interface Retinal Implanthttps://modernod.com/news/nejm-publishes-study-demonstrating-vision-restoration-with-brain-computer-interface-retinal-implant/2484211/The New England Journal of Medicine (NEJM) published results from a clinical trial demonstrating that Science Corporation’s PRIMA brain-computer interface (BCI) retinal implant can restore functional
- FDA Selects Dompé for National Priority Voucher Program to Accelerate Development of Novel Intranasal Therapyhttps://modernod.com/news/fda-selects-dompe-for-national-priority-voucher-program-to-accelerate-development-of-novel-intranasal-therapy/2484190/Dompé announced its selection by the FDA to participate in the Commissioner’s National Priority Voucher (CNPV) program. Through this designation, Dompé has been awarded a voucher granting a signific
- Topcon Healthcare Signs Definitive Agreement to Acquire Toku Inc.https://modernod.com/news/topcon-healthcare-signs-definitive-agreement-to-acquire-toku-inc/2484189/Topcon Healthcare announced it has signed a definitive agreement to acquire Toku, Inc., a San Diego-based artificial intelligence (AI) health technology company. Financial terms of the deal were not disclosed.
- OcuSciences Secures CE Mark for OcuMet Beacon, Expands European Deploymenthttps://modernod.com/news/ocusciences-secures-eu-ce-clearance-for-ocumet-beacon-expands-european-deployment/2484181/OcuSciences has received CE Mark clearance for its OcuMet Beacon, a diagnostic instrument designed to enhance clinicians’ ability to assess eye health and detect retinal disorders. The CE mark signifies that the OcuMet Beacon meets the health, safet
- CORE Highlights Emerging Focus on Pre-Myopia in Latest Contact Lens Updatehttps://modernod.com/news/core-highlights-emerging-focus-on-pre-myopia-in-latest-contact-lens-update/2484173/The Centre for Ocular Research & Education (CORE) has released the newest edition of Contact Lens Update, spotlighting the growing clinical and scientific interest in pre-myopia. This evolving area of study is reshaping how clinicians assess risk, intervene ear
- Heidelberg and NetraMind Collaborate to Deliver AI-Powered Choroid Analysis on AppWay Marketplacehttps://modernod.com/news/heidelberg-and-netramind-collaborate-to-deliver-ai-powered-choroid-analysis-on-appway-marketplace/2484166/Heidelberg Engineering announced a new collaboration with NetraMind Innovations, an AI-driven image analysis software company founded by retinal specialists and machine learning engineers. Their new application, NMI-ChoroidAI,* is now available via the Heidelb
- Generational Differences Drive Contact Lens Choices and Technology Appeal, New Research Findshttps://modernod.com/news/generational-differences-drive-contact-lens-choices-and-technology-appeal-new-research-finds/2484156/The motivations for wearing contact lenses and the appeal of new lens technologies vary significantly by generation, according to new research from the Contact Lens Institute (CLI) to be presented this week at the 2025 American Academy of Optometry annual meet
- SightGlass Vision: New 18-Month Data Reinforce DOT Lens Effectivenesshttps://modernod.com/news/sightglass-vision-new-18-month-data-reinforce-dot-lens-effectiveness/2484152/New 18-month clinical data presented by SightGlass Vision at the American Academy of Optometry 2025 annual meeting show that more than half of children wearing DOT spectacle lenses experienced no clinically meaningful myopia progression—nearly 4 times th